drugset / Trial / NCT01571570
A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the relative bioavailability and the short-term safety and tolerability of TMC435 following administration of 3 single oral doses of 150 mg, given as different formulations in healthy adult participants. In addition, this study is to assess for the acceptability of the taste of both liquid formulations.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simeprevir | Small molecule | 150 mg | Oral |
Indications
No indication recorded.